Clinical Trial

Ovarian Cancer Screening and AI

Study acronym: AI-OCS-Gyn
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 31, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Gynecologists frequently overestimate the benefits and safety of ovarian cancer screening. AI-supported discussions may help correct these misperceptions. This study tests whether an AI-guided conversation about the evidence on ovarian cancer screening can improve gynecologists' knowledge and reduce non-evidence-based screening recommendations, compared with a control AI discussion on ovarian cancer prevalence.
Trial Details
NCT Number NCT07503054
Lead Sponsor Charite University, Berlin, Germany
Collaborators: Max Planck Institute for Human Development, German Research Foundation
Conditions Ovarian Cancer Screening Recommendations by Gynecologists
Enrollment 350 participants
Start Date 2026-03-27
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-31